AI-Driven Diagnosis and Medical Applications Leveraging Multimodal Data
Artificial Intelligence (AI) is revolutionizing the healthcare industry by enhancing diagnostic accuracy and enabling personalized treatment plans.
Artificial Intelligence (AI) is revolutionizing the healthcare industry by enhancing diagnostic accuracy and enabling personalized treatment plans.
The first two tools are very similar. They use engineering relationships established through physics and solve those relationships through approximate or closed-form techniques. The third method is purely based on data.
1&2 use engineering relationships established through physics and solve those relationships through numerical or closed-form techniques. 3 is purely based on data.
The global EPC (Engineering, Procurement, and Construction) industry accounted for 7.5% of the global GDP in 2022 and is growing at a rate 2-3% higher than the GDP growth rate.
Many years back I was looking for good algorithms for an online estimation of the parameters of a parallel robot mainly for self-calibration. I applied traditional nonlinear Optimization after modelling higher-degree nonlinearities as noises.
Today AI seems to be everywhere and is trying to automate almost everything we use or interact with daily. But somehow the large-scale industrial systems seem to adapt to the application of AI slower than expected.
In the rapidly evolving landscape of healthcare, the integration of advanced technologies and data science is reshaping the way we diagnose, treat, and manage diseases.
One of the most important factors that influences decision making across industries is data. The medical industry is no different. From medical research and clinical trials to introducing new treatments, sound medical data is a key component.
Innovation can be a driving force for quality improvement — synthetic data, robust analytics, and AI-powered testing tools can uncover answers at a faster pace than today‘s cumbersome, resource-heavy, disjointed test data management processes. I
In my 20+ years of association with healthcare and life sciences industry, I found that medical product companies often face fragmented data assets, limited access to clinical information, and lengthy development processes.